Awantia

Awarded

Aciclovir (CRE)

Buyer
GWQ ServicePlus AG
Winners
Hexal AG
Contract value
no value published
Bids received
2
Published
7 Aug 2026
Awarded
14 Jul 2026
Contract start
1 Oct 2026
Contract end
31 Dec 2028stated
Sector
Medical equipment and pharmaceuticals
Region
Nordrhein-Westfalen (DEA11)
Source
Original notice on TED (553409-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
Valganciclovir (FTA)GWQ ServicePlus AGAmarox Pharma GmbH, PUREN Pharma GmbH & Co. KG, Viatris Healthcare GmbH, Zweigniederlassung Bad Homburg—11 Aug 2026
Ticagrelor (FTA)GWQ ServicePlus AG089Pharm GmbH, Ascend GmbH, Zentiva Pharma GmbH—11 Aug 2026
Temozolomid (HKP)GWQ ServicePlus AGAccord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, Fairmed Healthcare GmbH, medac GmbH—11 Aug 2026
Telmisartan + HCT (TAB, FTA)GWQ ServicePlus AGBG Heumann / Heunet GbR, Micro Labs GmbH, Zentiva Pharma GmbH—11 Aug 2026
Telmisartan (TAB, FTA)GWQ ServicePlus AGMedical Valley Invest AB, Micro Labs GmbH, Zentiva Pharma GmbH—11 Aug 2026
Tapentadol (RET)GWQ ServicePlus AGBG ALIUD / STADAPHARM GbR, G.L. Pharma Deutschland GmbH, Micro Labs GmbH—11 Aug 2026